Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study will examine whether the addition of cognitive behavioral therapy can improve the
efficacy of the medication paroxetine (Paxil®) in treating individuals with social anxiety
disorder. Patients with social anxiety disorder will undergo a 12-week open trial with
paroxetine. Those who complete the open trial having achieved only partial response will be
randomized to receive cognitive behavioral therapy (CBT) in addition to paroxetine or to
continue on paroxetine alone for an additional 16 weeks.